will fda ban compounded semaglutide 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compounded "semaglutide" is not FDA-approved

According to the NIH (National Institute of Health), just 5% reduction from baseline weight is associated with meaningful clinical improvement

Its triple-receptor action may provide more comprehensive effects than single-target medications

At re:vitalize, our programs promote metabolic health and address the root causes of weight gain, equipping you with the tools needed to enjoy lasting success, without the need to obsessively track or restrict calories

Given the benefits of this class of medication, it is likely more approvals for more indications will be on the horizon

Goldman has authored 14 medical textbooks and more than 400 peer-reviewed publications

Just this month, on January 29, 2026, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued an important update for patients and prescribers